Mylan Labs Ltd Company Profile
What is the competitive landscape for MYLAN LABS LTD
MYLAN LABS LTD has sixty-six approved drugs.
There are seven tentative approvals on MYLAN LABS LTD drugs.
Summary for Mylan Labs Ltd
| US Patents: | 0 |
| Tradenames: | 53 |
| Ingredients: | 51 |
| NDAs: | 66 |
Drugs and US Patents for Mylan Labs Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Labs Ltd | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 206091-002 | Oct 26, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Labs Ltd | HALOPERIDOL DECANOATE | haloperidol decanoate | INJECTABLE;INJECTION | 075440-002 | Feb 28, 2000 | AO | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Labs Ltd | FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 204015-001 | Sep 5, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
